Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ResistAZM: Ceftriaxone +/- Azithromycin for Gonorrhea
NCT05027516Phase 4Completed
- Sponsor
- Institute of Tropical Medicine Antwerp
- Start
- Jan 2022
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin in gonorrhea, sponsored by Institute of Tropical Medicine Antwerp. Started Jan 2022; status: completed.
02
Drugs
azithromycin
03
Conditions
gonorrhea
Beyond the preview
Go deeper on NCT05027516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05027516.